Active Ingredient History
Triamcinolone hexacetonide is a synthetic glucocorticoid corticosteroid. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adrenal Hyperplasia, Congenital (approved 1957)
Dermatitis Herpetiformis (approved 1957)
Lymphoma (approved 1957)
Rhinitis, Allergic, Perennial (approved 1996)
Rhinitis, Allergic, Seasonal (approved 1957)
Uveitis (approved 1957)
Abdominal Injuries (Phase 4)
Abdominal Pain (Phase 4)
Acne Vulgaris (Phase 2)
Adenomyosis (Early Phase 1)
Adipose Tissue (Phase 2)
Adiposity (Phase 4)
Adrenal Insufficiency (Phase 4)
Alopecia (Phase 4)
Alopecia Areata (Phase 4)
Anesthesia, Epidural (Phase 4)
Anterior Cruciate Ligament Injuries (Phase 2)
Arthritis (Phase 4)
Arthritis, Gouty (Phase 3)
Arthritis, Juvenile (Phase 4)
Arthritis, Psoriatic (Phase 4)
Arthritis, Rheumatoid (Phase 2)
Arthroplasty, Replacement, Knee (Phase 4)
Asthma (Phase 2)
Blood Pressure (Phase 3)
Bone Diseases (Phase 4)
Breast Neoplasms (Phase 2)
Bursitis (Phase 4)
Carpal Tunnel Syndrome (Phase 4)
Cataract (Phase 4)
Cell- and Tissue-Based Therapy (Phase 1/Phase 2)
Central Serous Chorioretinopathy (Phase 2/Phase 3)
Cervix Uteri (Phase 4)
Chalazion (Phase 3)
Cholecalciferol (Early Phase 1)
Choroidal Effusions (Phase 4)
Choroidal Neovascularization (Phase 3)
Chronic Pain (Phase 4)
Cicatrix, Hypertrophic (Phase 4)
Complex Regional Pain Syndromes (Phase 4)
Connective Tissue Diseases (Phase 4)
Contracture (Phase 4)
Corneal Edema (Phase 3)
Coronary Disease (Phase 2)
Cough (Phase 3)
Cystitis, Interstitial (Phase 4)
De Quervain Disease (Phase 3)
Dermatitis, Allergic Contact (Phase 2/Phase 3)
Dermatitis, Atopic (Phase 4)
Dermatitis, Contact (Phase 4)
Dermatitis, Occupational (Phase 4)
Dermatology (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 3)
Drug Interactions (Phase 1)
Dupuytren Contracture (Phase 4)
Dyspareunia (Phase 4)
Eczema (Phase 4)
Elbow (Phase 2/Phase 3)
Endodontics (Phase 4)
Esophageal Stenosis (Phase 4)
Exanthema (Phase 2)
Exercise (Phase 4)
Eye Diseases (Phase 3)
Facial Pain (Phase 4)
Fat Body (Phase 4)
Fibroma (Phase 4)
Fibrosis (Phase 4)
Fissure in Ano (Phase 4)
Flail Chest (Phase 2/Phase 3)
General Surgery (Phase 2/Phase 3)
Geographic Atrophy (Phase 2)
Glaucoma (Phase 4)
Glioblastoma (Phase 2)
Glucocorticoids (Phase 3)
Gout (Phase 4)
Graves Ophthalmopathy (Phase 4)
Hand Dermatoses (Phase 2)
Headache (Phase 4)
Hearing Loss, Sensorineural (Phase 1)
Hemorrhoids (Phase 4)
Hidradenitis Suppurativa (Phase 4)
Humeral Fractures (Early Phase 1)
Infections (Phase 4)
Inflammation (Phase 4)
Injections (Phase 4)
Intraocular Pressure (Phase 4)
Intravitreal Injections (Phase 2/Phase 3)
Joint Diseases (Phase 4)
Keloid (Phase 4)
Knee (Phase 2)
Leber Congenital Amaurosis (Phase 1/Phase 2)
Leiomyoma (Early Phase 1)
Lens Diseases (Phase 3)
Lichen Planus (Phase 2)
Lichen Planus, Oral (Phase 4)
Ligaments (Phase 4)
Ligaments, Articular (Phase 4)
Low Back Pain (Phase 4)
Lumbar Vertebrae (Phase 4)
Lung Diseases (Phase 3)
Lung Diseases, Obstructive (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Macular Degeneration (Phase 4)
Macular Edema (Phase 4)
Magnetic Resonance Imaging (Phase 2)
Melanoma (Phase 4)
Melanosis (Phase 2/Phase 3)
Meniscus (Phase 4)
Mesenchymal Stem Cells (Phase 1/Phase 2)
Morton Neuroma (Phase 4)
Mucositis (Phase 1/Phase 2)
Musculoskeletal Diseases (Phase 4)
Mycosis Fungoides (Phase 2)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 2)
Myofascial Pain Syndromes (Phase 4)
Myofascial Release Therapy (Phase 4)
Nail Diseases (Phase 4)
Nasal Obstruction (Phase 4)
Nasal Polyps (Phase 2/Phase 3)
Neck Pain (Phase 4)
Neoplasms (Phase 4)
Neoplasms by Histologic Type (Phase 4)
Neoplasms, Connective and Soft Tissue (Phase 4)
Neoplasms, Connective Tissue (Phase 4)
Neoplasms, Fibrous Tissue (Phase 4)
Neovascularization, Pathologic (Phase 2/Phase 3)
Nerve Block (Phase 3)
Neuralgia (Early Phase 1)
Neuroma, Acoustic (Phase 1)
Ophthalmology (Phase 2/Phase 3)
Optic Neuropathy, Ischemic (Phase 3)
Orbital Pseudotumor (Phase 3)
Osteoarthritis, Hip (Phase 3)
Osteoarthritis, Knee (Phase 4)
Otitis Media with Effusion (Phase 3)
Pain ()
Pain, Postoperative (Phase 4)
Pancreatitis, Chronic (Phase 3)
Panuveitis (Phase 3)
Papilledema (Early Phase 1)
Paranasal Sinus Diseases (Phase 3)
Paresis (Phase 2)
Pars Planitis (Phase 2/Phase 3)
Pelvic Organ Prolapse (Phase 4)
Pemphigoid, Benign Mucous Membrane (Phase 2/Phase 3)
Pemphigus (Phase 3)
Pentoxifylline (Phase 4)
Pharmacokinetics (Phase 4)
Physical Functional Performance (Phase 4)
Pigmentation Disorders (Phase 2)
Postoperative Complications (Phase 4)
Precancerous Conditions (Phase 2)
Prostatic Neoplasms (Phase 1)
Psoriasis (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Radiculopathy (Phase 4)
Rectal Fistula (Phase 4)
Retinal Detachment (Phase 4)
Retinal Diseases (Phase 4)
Retinal Vein Occlusion (Phase 4)
Retinoschisis (Phase 4)
Rhinitis (Phase 3)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Perennial (Phase 4)
Rhinitis, Allergic, Seasonal (Phase 3)
Rotator Cuff Injuries (Phase 4)
Shoulder Impingement Syndrome (Phase 4)
Shoulder Injuries (Phase 3)
Shoulder Pain (Phase 4)
Sinusitis (Phase 4)
Sleep Apnea, Obstructive (Phase 3)
Spinal Stenosis (Phase 4)
Spondylosis (Phase 4)
Sprains and Strains (Phase 4)
Stem Cells (Phase 4)
Stomach Diseases (Phase 4)
Stroke (Phase 4)
Synovitis (Phase 4)
Temporomandibular Joint (Phase 4)
Tendinopathy (Phase 4)
Tennis Elbow (Phase 4)
Tenosynovitis (Phase 4)
Therapeutics (Phase 2)
Thyroid Gland (Phase 2)
Tibial Meniscus Injuries (Phase 2)
Tissues (Phase 3)
Traumatology (Phase 3)
Triamcinolone (Phase 4)
Triamcinolone Acetonide (Phase 3)
Trigger Finger Disorder (Phase 4)
Uveitis (Phase 4)
Uveitis, Anterior (Phase 3)
Uveitis, Intermediate (Phase 3)
Uveitis, Posterior (Phase 3)
Uveomeningoencephalitic Syndrome (Phase 2/Phase 3)
Vascular Diseases (Phase 2)
Vasoconstriction (Phase 1)
Vitamin E (Phase 4)
Vitiligo (Phase 2/Phase 3)
Vitrectomy (Phase 3)
Vitreoretinopathy, Proliferative (Phase 4)
Vocal Cord Dysfunction (Phase 4)
Wet Macular Degeneration (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
